{
    "2019-02-11": [
        [
            {
                "time": "2018-04-10",
                "original_text": "SEC's Clayton says agency right not to rule on Johnson & Johnson shareholder proposal concerning mandatory arbitration",
                "features": {
                    "keywords": [
                        "SEC",
                        "Clayton",
                        "Johnson & Johnson",
                        "shareholder proposal",
                        "mandatory arbitration"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "FDA Panel Reviews Johnson & Johnson's Treatment-Resistant Depression Candidate: What To Expect",
                "features": {
                    "keywords": [
                        "FDA",
                        "Panel",
                        "Johnson & Johnson",
                        "Treatment-Resistant Depression",
                        "Candidate"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "What Are Analysts Saying About Johnson & Johnsonâ€™s (NYSE:JNJ) Growth?",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Johnson & Johnson",
                        "Growth"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}